Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-25-000780
Filing Date
2025-08-14
Accepted
2025-08-14 18:03:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7163
2 JOINT FILING AGREEMENT ss5209502_ex99a.htm EX-99.A 6231
  Complete submission text file 0000947871-25-000780.txt   15082
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SCHEDULE 13G/A

Mailing Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043
Business Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043 6502372700
NeuroPace Inc (Subject) CIK: 0001528287 (see all company filings)

EIN.: 223550230 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92504 | Film No.: 251221509
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)